Bronstein, Gewirtz & Grossman, LLC has filed a class action lawsuit against Park Ha Biological Technology Co., Ltd. and certain officers, alleging violations of federal securities laws. The suit covers investors who purchased Park Ha securities between December 27, 2024 and July 8, 2025. The complaint claims the company failed to disclose a fraudulent stock promotion and market manipulation scheme involving social media misinformation and impersonation of financial professionals, and that its IPO was structured with an extremely low public float to facilitate the manipulation. Investors have until September 21, 2026 to seek lead plaintiff appointment. The firm represents investors on a contingency fee basis.
Park Ha Biological Technology Co., Ltd.Class action lawsuit alleging securities law violations and fraudulent stock promotion.